Stratos Wealth Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,181
| Closed | -$341K | – | 1382 |
|
|
2024
Q4 | $341K | Sell |
5,181
-241
| -4% | -$15.8K | ﹤0.01% | 1091 |
|
|
2024
Q3 | $381K | Sell |
5,422
-4
| -0.1% | -$281 | 0.01% | 1041 |
|
|
2024
Q2 | $447K | Hold |
5,426
| – | – | 0.01% | 942 |
|
|
2024
Q1 | $474K | Sell |
5,426
-283
| -5% | -$24.7K | 0.01% | 917 |
|
|
2023
Q4 | $550K | Buy |
5,709
+115
| +2% | +$11.1K | 0.01% | 840 |
|
|
2023
Q3 | $495K | Buy |
+5,594
| New | +$495K | 0.01% | 822 |
|
|
2018
Q4 | – | Sell |
-498
| Closed | -$48K | – | 1004 |
|
|
2018
Q3 | $48K | Buy |
+498
| New | +$48K | ﹤0.01% | 1475 |
|
|
2018
Q2 | – | Sell |
-512
| Closed | -$42K | – | 1148 |
|
|
2018
Q1 | $42K | Buy |
512
+325
| +174% | +$26.7K | ﹤0.01% | 1664 |
|
|
2017
Q4 | $17K | Buy |
+187
| New | +$17K | ﹤0.01% | 1961 |
|